For example, dietary supplementation with a glycomacropeptide derived from casein for 12 weeks decreased insulin and HOMA-IR but did not protect against high-fat/high-sugar diet-induced obesity or improve OGTT in C57BL/6 mice [115]. The gene discussed is INS; the disease is obesity disorder.